drugset / Trial / NCT00004406

Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis

NCT00004406 ↗

Completed 36 enrolled Columbia University
RandomizedDouble-blindTreatment

Summary

OBJECTIVES: I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men with idiopathic osteoporosis.

Timeline

Start
1999-10
Primary completion
—
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject human parathyroid hormone Unknown — Subcutaneous

Indications